These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7563866)

  • 1. [High risk group for evolution of hepatocellular carcinoma from HCV related liver cirrhosis].
    Hayashi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):736-9. PubMed ID: 7563866
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk factors for development of hepatocellular carcinoma in patients with liver cirrhosis associated with hepatitis C virus].
    Matsushita E; Unoura M; Kaneko S; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):727-30. PubMed ID: 7563864
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.
    Roudot-Thoraval F; Bastie A; Pawlotsky JM; Dhumeaux D
    Hepatology; 1997 Aug; 26(2):485-90. PubMed ID: 9252163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of heavy drinking for the development of hepatocellular carcinoma in type C cirrhosis].
    Chiba T; Tanaka N
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):731-5. PubMed ID: 7563865
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients].
    Tarao K; Ohkawa S; Tamai S; Shimizu A
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):740-5. PubMed ID: 7563867
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
    Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K
    Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G; Llovet JM
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract]   [Full Text] [Related]  

  • 10. [HCV infection among cirrhotic patients as a risk factor for generation of hepatocellular carcinoma: preliminary report].
    Kobayashi S; Nagai Y; Nakao T; Nogami H; Isono K
    Nihon Geka Gakkai Zasshi; 1991 Nov; 92(11):1666. PubMed ID: 1722866
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
    Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
    Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natural history of HCV infection].
    Trinchet JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B144-53. PubMed ID: 12180282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis-C virus and hepatoma].
    Zala G; Havelka J; Altorfer J; Joller-Jemelka HJ; Risti B; Meier B; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1992 Feb; 122(6):194-7. PubMed ID: 1311125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and hepatocellular carcinoma: grist for the mill.
    Sherman M
    Gastroenterology; 2009 Jan; 136(1):39-42. PubMed ID: 19041651
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma: pathogenetic implications of the hepatitis delta virus.
    Oliveri F; Colombatto P; Derenzini M; Trere D; Papotti M; David E; Negro F; Bellati G; Ideo G; D'Aquino M
    Prog Clin Biol Res; 1993; 382():165-70. PubMed ID: 8389050
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical features of hepatitis C virus-related liver cancer].
    Ikeda K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):764-9. PubMed ID: 7563872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.